Skip to main navigation Skip to search Skip to main content

Recombinant deoxyribonucleoside kinase from Drosophila melanogaster can improve gemcitabine based combined gene/chemotherapy for targeting cancer cells

  • Mahak Fatima
  • , Muhammad Mubashar Iqbal Iqbal
  • , Faiza Batool
  • , Anjum Riaz
  • , Ali Moazzam
  • , Moazzam Ali
  • , Birgitte Munch-Petersen
  • , Zeeshan Mutahir

    Research output: Contribution to journalArticleScientificpeer-review

    Original languageEnglish
    Pages (from-to)342-349
    JournalBosnian Journal of Basic Medical Sciences
    Volume19
    Issue number4
    DOIs
    Publication statusPublished - 2019
    Publication typeA1 Journal article-refereed

    UN SDGs

    This output contributes to the following UN Sustainable Development Goals (SDGs)

    1. SDG 3 - Good Health and Well-being
      SDG 3 Good Health and Well-being

    Keywords

    • breast cancer
    • drosophila melanogaster deoxyribonucleoside kinase
    • drug resistance
    • gemcitabine
    • suicide gene therapy

    Publication forum classification

    • Publication forum level 0

    Cite this